American Shared Hospital ... (AMS)
2.68
-0.07 (-2.55%)
At close: Apr 28, 2025, 3:39 PM
2.68
0.00%
After-hours: Apr 28, 2025, 02:54 PM EDT
American Shared Hospital Services Revenue Breakdown
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|
| Patient Income Revenue | 3.69M | 3.16M | 963K | 1.11M | 988K | 756K | 696K | 764K | 727K | 894K |
| Patient Income Revenue Growth | +16.79% | +227.83% | -13.48% | +12.65% | +30.69% | +8.62% | -8.90% | +5.09% | -18.68% | n/a |
| Rental Income from Medical Services Revenue | 3.31M | 3.9M | 4.25M | 9.6M | 3.95M | n/a | 4.23M | 4.27M | 4.1M | 4.14M |
| Rental Income from Medical Services Revenue Growth | -15.06% | -8.32% | -55.68% | +143.21% | n/a | n/a | -1.03% | +4.19% | -0.94% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2022 | Dec 31, 2021 |
|---|---|---|
| Domestic Segment Revenue | 16.66M | 14.72M |
| Domestic Segment Revenue Growth | +13.15% | n/a |
| Foreign Segment Revenue | 3.09M | 2.91M |
| Foreign Segment Revenue Growth | +6.26% | n/a |
Operating Expense Breakdown
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 1.92M | 1.9M | 1.84M | 1.76M | 1.74M | 1.99M | 1.54M | 1.42M | 1.26M | 1.15M | 1.32M | 1.24M | 1.12M | 1.09M | 1.08M | 1.05M | 1.14M | 1.21M | 1.21M | 859K | 1.06M | 1.08M | 1.05M | 927K | 1.05M | 1.03M | 986K | 1.02M | 1.03M | 1.14M | 1.14M | 891K | 999K | 963K | 949K | 792K | 904K | 979K | 821K |
| Selling, General, and Administrative Revenue Growth | +1.42% | +2.93% | +4.66% | +1.44% | -12.73% | +29.17% | +8.38% | +12.70% | +9.95% | -13.12% | +6.54% | +10.63% | +2.66% | +0.55% | +3.04% | -7.31% | -6.20% | -0.08% | +40.98% | -19.34% | -1.48% | +2.46% | +13.81% | -11.71% | +1.74% | +4.67% | -3.33% | -0.58% | -9.84% | -0.09% | +27.83% | -10.81% | +3.74% | +1.48% | +19.82% | -12.39% | -7.66% | +19.24% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |